Peptide-based immunotherapy in lupus: Where are we now? is a research paper published in Rheumatology and Immunology Research (2023). On theSindex it has a DataRank of 0. It has been cited 7 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NIAID NIH HHS
Grant: R21 AI083894
NIAMS NIH HHS
Grant: R03 AR054034
NIAID NIH HHS
Grant: R21 AI065645
National Institutes of Health
Grant: 5R21AI083894-02
Role of Sex Differences in the Expression & Function of Regulatory T cells in SLE
National Institutes of Health
Grant: 5R03AR054034-03
Delineating the Role of Selected Genes in Lupus Induced by CD8+Ti and CD4+CD25 T
National Institutes of Health
Grant: 5R21AI065645-02
Molecular Basis of Suppression of SLE by CD8+ Ti Cells
FWCI
1.31
Citation Percentile
0.8%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals